Director of Marketing and
American Association for Thoracic
David H. Adams Assumes Presidency
of the American Association for Thoracic Surgery
Vaughn A. Starnes Named President-Elect, Marc
R. Moon is Elected Vice President,
and David R. Jones is Secretary.
SAN DIEGO – May 3, 2018
– David H. Adams, MD, became the 99th President of the American
Association for Thoracic Surgery (AATS) Monday evening. He officially succeeded
Duke E. Cameron, MD, in a ceremony at the AATS 98th Annual Meeting
in San Diego.
A recognized leader in the field of heart valve
surgery and mitral valve reconstruction, Dr. Adams is the Marie-Josée and Henry R. Kravis Professor and Chairman of the
Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai and the Cardiac Surgeon-in-Chief of the
Mount Sinai Health System. He is also President of the Mitral Foundation, a not-for-profit
organization dedicated to promoting best practice standards in mitral valve
disease and supporting medical missions that advance the repair skills of
surgeons in developing countries.
As the Program Director of The Mount Sinai Hospital Mitral Valve Repair Reference Center, he directs one of the largest programs in the United States. Dr.
Adams and his team perform over 450 mitral valve operations per year while
setting national benchmarks for clinical outcomes.
Dr. Adams received his undergraduate and medical education at Duke University, and completed his internship, research fellowship, and residencies in general and cardiothoracic surgery at Brigham and Women's Hospital and Harvard Medical School. During his tenure at Mount Sinai he co-authored the internationally acclaimed and widest selling valve textbook in history, Carpentier's Reconstructive Valve Surgery, and also co-edited the benchmark reference textbook Cardiac Surgery in the Adult. He is also an Associate Editor for Surgery for the Journal of the American College of Cardiology. He has also invented or co-invented multiple mitral or tricuspid repair rings that are used throughout the world, and currently serves as the National Co-Principal Investigator of multiple FDA pivotal randomized trials in the field of transcatheter valve intervention.
He has been an active member of the AATS, the oldest and most
prestigious organization dedicated to cardiothoracic surgery, since 1999. He is
the Director of the biennial AATS Mitral Conclave, the largest
international meeting in the world focused on mitral valve disease, and a
co-director of the annual American College of Cardiology - AATS Heart Valve Summit. He has served as
part of the AATS Council and Executive Committee, for the
past five years, providing oversight of the association’s management and
him in new positions on the Executive Committee are Vaughn A. Starnes, MD, who
is now the President-Elect after serving as Vice President for the last year, Marc
R. Moon, MD, who was elected as the new AATS Vice President, and David R. Jones,
MD, who becomes Secretary following a year as Secretary-Elect. In addition,
Thierry Carrel, MD, of the University Hospital Bern joins the Council as an International Councilor.
Dr. Starnes is Distinguished Professor and
Chairman of the Department of Surgery, Keck School of Medicine, University of
Southern California, and the Co-Director of the Heart Institute at Children’s
Hospital Los Angeles. He received his medical degree from the University of
North Carolina, Chapel Hill, and did his general surgery training, as well as
two years of research in cardiothoracic physiology and pharmacology at
Vanderbilt University. He spent two years as a resident in cardiovascular
surgery, and one year as chief resident in cardiac transplantation at Stanford
University, then did a fellowship in pediatric cardiovascular surgery at the
Hospital for Sick Children in London before returning to Stanford. He has been
at USC since 1992 and has been Chairman of the Department of Cardiothoracic
Surgery since 1997.
Dr. Moon most recently served as the AATS
Secretary for five years. He is the Chief of Cardiac Surgery, the Program
Director for the Thoracic Surgery Residency Program, and the John M. Shoenberg
Professor of Surgery at the Washington University School of Medicine in St.
Louis. A graduate of the University of Michigan, he received his medical degree
from Wayne State University. He completed his residency in general surgery at
the Medical College of Wisconsin, which included a one-year period of training
in vascular surgery at Oxford University in England, and two years in the
cardiovascular physiology laboratory at Stanford. He completed his
cardiothoracic surgery training at Stanford in 1998.
Dr. Jones is the Fiona &
Stanley Druckenmiller Chair of Lung Cancer Research, Chief of Thoracic Surgery
and Co-Director of the Druckenmiller Center for Lung Cancer Research at
Memorial Sloan Kettering Cancer Center. He is past president of the Southern
Thoracic Surgical Association, Examination Chair for the American Board of
Thoracic Surgery, and leads the AATS Thoracic Surgical Oncology Group. He was one of the first thoracic
surgeons to develop expertise in VATS approaches for lung and esophageal
cancer. Dr. Jones has maintained a funded translational research laboratory for
20 years studying the biology of lung cancer metastases. He received his
medical degree and completed his general surgery residency at West Virginia
University. He did his thoracic surgery residency and a fellowship in molecular
oncology at the University of North Carolina – Chapel Hill.
ABOUT THE AMERICAN ASSOCIATION
FOR THORACIC SURGERY (AATS)
The American Association for
Thoracic Surgery (AATS) is an international organization that encourages,
promotes, and stimulates the scientific investigation of cardiothoracic
surgery. Founded in 1917 by a respected group of the earliest pioneers in the field,
its original mission was to “foster the evolution of an interest in surgery of
the Thorax.” Today, the AATS is the premiere association for cardiothoracic
surgeons in the world and works to continually enhance the ability of
cardiothoracic surgeons to provide the highest quality of patient care. Its
more than 1400 members have a proven record of distinction within the specialty
and have made significant contributions to the care and treatment of
cardiothoracic disease. Visit www.aats.org to